Mayne Pharma To Pay US$650K To End US Antitrust Claim
By Antony Scholefield · September 28, 2026, 8:25 PM AEST
Mayne Pharma said Monday it would pay US$650,000 (AU$927,000) to settle a complaint by 49 U.S. attorneys general alleging antitrust violations in its marketing of a generic version of the antibiotic...
To view the full article, register now.
Try Law360 Australia FREE for fourteen days
Already a subscriber? Click here to login